...
首页> 外文期刊>Annals of oncology: official journal of the European Society for Medical Oncology >Anaphylactic shock secondary to intravenous administration of folinic acid: a first report.
【24h】

Anaphylactic shock secondary to intravenous administration of folinic acid: a first report.

机译:静脉注射亚叶酸导致的过敏性休克:首次报道。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Folates, components of the B-complex vitamins, have numerous pharmacological effects. In oncology combining folates with 5-fluorouracil (5-FU) enhances the cytotoxic effects of chemotherapy in colon cancer patients. Folic acid has been rarely involved in adverse allergic reactions. To the best of our knowledge no anaphylactic reaction secondary to folinic acid (FA) administration has ever been reported before. PATIENTS AND METHODS: An 80-year-old patient had adjuvant chemotherapy for colon cancer including FA and 5-FU and irinotecan as a second line agent after multiple metastases. RESULTS: Following FA administration anaphylactic shock occurred. Diagnosis was made according to the French method of adverse reactions monitoring. CONCLUSION: Anaphylactic shock may be an adverse reaction of FA in patients receiving chemotherapy for colon cancer.
机译:背景:叶酸是B族复合维生素的成分,具有许多药理作用。在肿瘤学中,叶酸与5-氟尿嘧啶(5-FU)联合使用可增强结肠癌患者化疗的细胞毒性作用。叶酸很少参与不良的过敏反应。据我们所知,从未有过亚叶酸(FA)引起的过敏反应的报道。患者和方法:一名80岁患者接受了多发性转移后结肠癌的辅助化疗,其中包括FA和5-FU和伊立替康作为二线药物。结果:FA给药后发生过敏性休克。根据法国不良反应监测方法进行诊断。结论:过敏性休克可能是接受结肠癌化疗的FA的不良反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号